Study: Remdesivir Prevented Lung Damage In Monkeys Infected With COVID-19

Gilead Sciences' experimental COVID-19 drug, remdesivir, reduced viral load and prevented lung disease in macaques infected with the coronavirus, according to a study published in the medical journal Nature.